Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement

By sjmartinez • May 18, 2025

Oprea AD, Ostapenko LJ, Sweitzer B, Selzer A, Irizarry-Alvarado JM, Hurtado Andrade MD, Mendez CE, Kelley KD, Stewart E, Fernandez Robles CR, Chadha RM, Camilleri M, Mathur R, Umpierrez GE, Hepner DL. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. Br J Anaesth. 2025 May 15:S0007-0912(25)00214-4. doi: 10.1016/j.bja.2025.04.001. Epub ahead of print. PMID: 40379536.

Tags: Cedars Sinai DoM, diabetes mellitus, Endocrinology, gastric emptying, glucagon-like peptide 1 receptor agonists, major adverse cardiovascular events, Obesity, perioperative care, Publications

Comparison, Agreement, and Significance Cutoffs of 18F-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software Packages

Packard RRS, Buckley C, Cooke CD, Moody JB, Renaud JM, Slomka P, Thompson D, Van Kriekinge SD, Van Train KF, Wangerin KA, Maddahi J. Comparison,[...]

The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET(REFINE PET): Rationale and Design

Ramirez G, Lemley M, Shanbhag A, Kwiecinski J, Miller RJH, Kavanagh PB, Liang JX, Dey D, Slipczuk L, Travin MI, Alexanderson E, Carvajal-Juarez I, Packard[...]

Interaction between haploinsufficiency of PTPN2 and patient microbiome promotes autoimmune arthritis in mice

Sendo S, Vela AJ, Ro M, Thiruppathy D, Wilkinson EL, Zhao Z, Hsieh WC, Yang S, Coras R, Bergot AS, Guma M, Nguyen A, McBride[...]